| |
Newsroom >
Business
>
Business
>
Tony Cataldo leads Genesis Biopharma with Extensive Experience in Managing Publicly Traded Companies
Tony Cataldo leads Genesis Biopharma with Extensive Experience in Managing Publicly Traded Companies
Chairman and CEO, Mr. Anthony Cataldo is sure that his vast experience spanning over two decades is sure to help Genesis Biopharma Inc.
Los Angeles,
CA,
United States of America
(sardnews.org)
01/07/2011
Ever since Genesis Biopharma Inc. producers of targeted cancer therapies, has announced that Mr. Anthony Cataldo shall be the Chairman and CEO of the company, there’s been a positive vibe that he’s sure to change the company’s prospects with his vast experience. Tony has more than 20 years f experience in managing publicly traded companies in various sectors including VoIP and media.
A former employee of the US Air Force, he brings along the rigors needed to lead a publicly traded company. He is also the Chairman, CEO and Director of Oxis International Inc., a position he has held since 2009. He has also served as a non executive Co-Chairman of the Board of MultiCell Technologies, a company that supplies functional non tumorigenic immortalized human hepatocytes. As the Chairman of the company, he led the company from a debt worth millions of dollars to success. From 2006 to 2008, he has served as Chairman and CEO of VoIP. He is also the CEO of the board of Green St. energy, a company that has forayed into the alternative energy business. From August 1995 to 1998, Tony Cataldo served as the President and Chairman at Senetak, PLC a company that’s involved in age related therapies.
“It’s very important that the biotechnology industry uses its experience and resources to find cure to chronic diseases and to help them recover quickly. A classic example is Genesis’s latest product that aims to cure Stage IV metastatic melanoma. Our Advisory board comprises of leading oncology researchers, and clinicians in the US. These personalized medicines are sure to help people suffering from chronic diseases. Research in biotechnology not only helps to save lives, but also manages to reduce health care costs and keep the country ahead when it comes to innovative therapeutics,” says Tony Cataldo when asked about his contribution to the company.
As earlier said, Tony has vast experience over a wide variety of industries including media and VoIp. He has served as the CEO and Chairman of the Board of Directors of Miracle Entertainment, Inc. where he was the executive producer of several motion pictures.
About Tony Cataldo: 58 year old Tony Cataldo is an inspiration to many in the biotechnology industry and has more than 2 decades of experience in handling publicly traded companies.
To know more, visit http://www.hotstocked.com/officers/a/anthony-j-cataldo-34488.html
###
About Genesis Biopharma, Inc
has also served as the President and Chairman of the Board of Senetek PLC, a biotechnology company that’s involved in age-related therapies.
About Genesis Biopharma: The Company is engaged in the development of targeted cancer therapies.
To know more, visit http://www.hotstocked.com/officers/a/anthony-j-cataldo-34488.html
|